Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.
about
Delivery of cancer screening: how important is the preventive health examination?Screening for breast cancer: an update for the U.S. Preventive Services Task ForceRisk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysisAverage household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy useInfluence of Computer-Aided Detection on Performance of Screening MammographyReported mammographic density: film-screen versus digital acquisitionCost of breast-related care in the year following false positive screening mammograms.Distinguishing screening from diagnostic mammograms using Medicare claims data.Actualizing Personalized Healthcare for Women through Connected Data Systems: Breast Cancer Screening and Diagnosis.Evaluation of an Automated Information Extraction Tool for Imaging Data Elements to Populate a Breast Cancer Screening Registry.Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.Radiologists' performance and their enjoyment of interpreting screening mammogramsDecreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors.Analysis of Participant Factors That Affect the Diagnostic Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea.Imaging Surveillance After Primary Breast Cancer Treatment.Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance?Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening populationRadiologists' attitudes and use of mammography audit reports.Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004.Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations.Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.Modelling the cumulative risk of a false-positive screening test.Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates.Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.Are there racial/ethnic disparities among women younger than 40 undergoing mammography?Feasibility and acceptability of conducting a randomized clinical trial designed to improve interpretation of screening mammography.Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy useDiagnosis of second breast cancer events after initial diagnosis of early stage breast cancerRelationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium.Evaluation and outcomes of women with a breast lump and a normal mammogram resultPairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees.Accuracy of screening mammography varies by week of menstrual cycle.Feasibility and satisfaction with a tailored web-based audit intervention for recalibrating radiologists' thresholds for conducting additional work-up.Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS).Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.Classification accuracy of claims-based methods for identifying providers failing to meet performance targets.Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk
P2860
Q24599996-57B3E1D3-9327-49F4-B479-A0BB18B08FB9Q24615837-76BD03AD-9201-4208-962E-73E5435F86E3Q24628928-19CE0F77-BBE8-4CA4-BFB9-5826AF19187FQ28220662-2D2A2D9C-4FCB-4740-AB59-3137439C6908Q29540997-1B038FA1-721A-44A7-8664-A2F945A39BB5Q30414634-C4FA595A-4079-4CAA-A632-DD6FEE48F16BQ30499746-ACB92CD6-195C-4E9C-A045-49E90FC50825Q30559155-951AF021-76A1-4FF3-A1CF-DC4A6D12C91CQ30731867-55135F39-2F6B-4606-B32C-0FABDC6CDA31Q30882845-4140DACF-4D5F-44F1-9E38-9A06D1D73E41Q31036427-B08F633F-EC0D-4DE0-A552-F6AEF49FCBBEQ33667241-F035F7BE-2A42-46C6-A172-32B18D540135Q33721920-57450BB3-AB3B-4F8B-B3C4-E6C1317492B3Q33736316-9E3BE77B-C9D0-483E-85B0-6FF2DB13D2D9Q33763563-D0A8104D-E133-4455-AC46-02207E087947Q33818628-D4FBA7E0-FAEB-47F2-BD64-63E1969203B4Q33903091-F1D6DAC2-C2D9-42B9-B157-EB4DF15DAE13Q33948720-08B50F53-4C04-4F25-91F8-E3265D02897CQ33952112-E1655FCD-E0E8-4AC0-833E-3F76FB4B774CQ33964312-7EB22D9C-B892-4949-8B9D-9C9C92EBF1BDQ33986348-28F5314F-3A1F-43A4-A686-0309B036C3F2Q34008973-69FFE861-873A-41F9-909E-9D63AFC961BCQ34044186-230E1349-9C5D-484E-9203-3B6028690625Q34069013-57A0B356-35B6-467E-A63F-638C502964A0Q34079901-91011762-7731-45F2-80C0-3BC0B18489E8Q34082172-125EF974-BD20-4AC9-A3F5-E4C7FCB85484Q34125368-C8806EAA-2B41-4EFB-BA0C-BFF61E0765D3Q34131826-8F2753B1-CF62-4405-8A95-C279D3F3D197Q34292779-C3621181-03D9-45D2-B468-B24664E4DC76Q34295251-6AD7E2DB-8ADC-419C-850F-B87B1B8E0786Q34324797-90E7F13E-AF7B-4F96-A9DC-C54B6A0B0EB3Q34362606-41B630D7-6A4B-4EEA-9CDC-298877236259Q34437884-0C079AE1-830F-4C36-A707-B20897AC725EQ34494526-22BE855B-982F-4B68-8744-D26D42602A93Q34534788-EF0D087D-3A67-4D63-9319-277E555CE74DQ34556546-F78C5586-5055-4569-A022-3BEE5DD1ACFDQ34573768-DE963521-83C1-46C2-9D25-719DFB4AAA61Q34590295-A6A50DB1-67A6-4699-A2D1-07B16861DD72Q34674227-9D2A6C3B-2D75-4382-873D-510312A493CBQ34687179-2804D979-5D18-42CD-A118-19885B85E6AF
P2860
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Breast Cancer Surveillance Con ...... reening and outcomes database.
@en
Breast Cancer Surveillance Con ...... reening and outcomes database.
@nl
type
label
Breast Cancer Surveillance Con ...... reening and outcomes database.
@en
Breast Cancer Surveillance Con ...... reening and outcomes database.
@nl
prefLabel
Breast Cancer Surveillance Con ...... reening and outcomes database.
@en
Breast Cancer Surveillance Con ...... reening and outcomes database.
@nl
P2093
P1476
Breast Cancer Surveillance Con ...... reening and outcomes database.
@en
P2093
Ballard-Barbash R
Chrvala CA
Edwards BK
Ernster VL
Kerlikowske K
Kessler LG
P304
P356
10.2214/AJR.169.4.9308451
P407
P577
1997-10-01T00:00:00Z